SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
This Quarter Return
+20.08%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$2.37B
AUM Growth
+$2.37B
(+8.4%)
Cap. Flow
-$178M
Cap. Flow
% of AUM
-7.51%
Top 10 Holdings %
Top 10 Hldgs %
42.39%
Holding
113
New
23
Increased
16
Reduced
30
Closed
11
Top Buys
| 1 |
Coca-Cola
KO
|
$33.4M |
| 2 |
Apple
AAPL
|
$30.3M |
| 3 |
CRH
CRH
|
$28.9M |
| 4 |
ArriVent BioPharma
AVBP
|
$27.9M |
| 5 |
argenx
ARGX
|
$26.9M |
Top Sells
| 1 |
Arcellx
ACLX
|
$60.8M |
| 2 |
Royalty Pharma
RPRX
|
$49.7M |
| 3 |
Las Vegas Sands
LVS
|
$36.3M |
| 4 |
Microsoft
MSFT
|
$34.8M |
| 5 |
Biohaven
BHVN
|
$31.2M |
Sector Composition
| 1 | Healthcare | 65.84% |
| 2 | Technology | 8.92% |
| 3 | Communication Services | 8% |
| 4 | Consumer Discretionary | 5.07% |
| 5 | Financials | 3.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Biohaven
BHVN
$1.63B
| $219M | 8.13% | 4,003,046 -569,790 | -12% | -$31.2M |
|
2
Kura Oncology
KURA
$686M
| $151M | 5.6% | 7,069,627 +123,397 | +2% | +$2.63M |
|
|
3
Arcellx
ACLX
$3.85B
| $109M | 4.04% | 1,562,354 -873,620 | -36% | -$60.8M |
|
4
Meta Platforms (Facebook)
META
$1.86T
| $84.3M | 3.13% | 173,605 -46,578 | -21% | -$22.6M |
|
5
Ultragenyx Pharmaceutical
RARE
$2.89B
| $78.3M | 2.91% | 1,676,811 -449,495 | -21% | -$21M |
|
6
Arcutis Biotherapeutics
ARQT
$1.86B
| $78.1M | 2.9% | 7,877,297 -595,804 | -7% | -$5.9M |
|
7
EyePoint Pharmaceuticals
EYPT
$797M
| $77.8M | 2.89% | 3,763,888 -292,959 | -7% | -$6.06M |
|
8
89bio
ETNB
$1.34B
| $73.3M | 2.72% | 6,298,004 +1,409,570 | +29% | +$16.4M |
|
|
9
Royalty Pharma
RPRX
$15.6B
| $68.3M | 2.54% | 2,250,361 -1,637,341 | -42% | -$49.7M |
|
|
ITCI
10
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $66.4M | 2.47% | 959,198 -206,750 | -18% | -$14.3M |
|
11
Amazon
AMZN
$2.44T
| $64.4M | 2.39% | 356,962 -11,127 | -3% | -$2.01M |
|
12
Advanced Micro Devices
AMD
$264B
| $61.7M | 2.29% | 341,699 +8,231 | +2% | +$1.49M |
|
13
Insmed
INSM
$28.8B
| $54.9M | 2.04% | 2,023,000 -661,487 | -25% | -$17.9M |
|
14
Cigna
CI
$80.3B
| $49.8M | 1.85% | 137,139 +40,839 | +42% | +$14.8M |
|
15
KalVista Pharmaceuticals
KALV
$678M
| $49.7M | 1.85% | 4,192,005 +1,508,000 | +56% | +$17.9M |
|
16
Verizon
VZ
$186B
| $49.5M | 1.84% | 1,179,452 +462,602 | +65% | +$19.4M |
|
|
17
argenx
ARGX
$43.6B
| $48M | 1.78% | 121,900 +68,200 | +127% | +$26.9M |
|
|
MRNS
18
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $46.2M | 1.72% | 5,108,520 -237,599 | -4% | -$2.15M |
|
19
Goldman Sachs
GS
$226B
| $45.9M | 1.7% | 109,890 -420 | -0.4% | -$175K |
|
20
TSMC
TSM
$1.2T
| $44.8M | 1.66% | 329,352 -58,880 | -15% | -$8.01M |
|
21
AT&T
T
$209B
| $42.2M | 1.57% | 2,398,619 +1,178,539 | +97% | +$20.7M |
|
22
Apollo Global Management
APO
$77.9B
| $41.7M | 1.55% | 370,636 -170,184 | -31% | -$19.1M |
|
23
Ferguson
FERG
$46.4B
| $37M | 1.37% | 169,280 -6,810 | -4% | -$1.49M |
|
24
GE Aerospace
GE
$292B
| $36.4M | 1.35% | 207,447 -148,733 | -42% | -$26.1M |
|
|
25
Coca-Cola
KO
$297B
| $33.4M | 1.24% | +546,500 | New | +$33.4M |
|